Psychedelic Therapy Developer MAPS PBC Closes $100M Series A, Rebrands as Lykos Therapeutics

The affiliate of the Multidisciplinary Association for Psychedelic Studies launched the fundraising effort to support its New Drug Application for an investigational, MDMA-assisted therapy for post-traumatic stress disorder.

Scroll to Top